VARGATEF DESIGN

Trademark usage description

pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology.

Vienna Information

1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 5

Astronomic orbitsOrbites astronomiques

26 . 7 . 4

Circles or ellipses with lines (except 26.7.3)Cercles ou ellipses avec lignes (excepté 26.7.3)

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 1 . 1

CirclesCercles

26 . 1 . 4

Two circles, two ellipses, one inside the otherDeux cercles, deux ellipses, l'un dans l'autre

26 . 1 . 12

Circles or ellipses containing one or more other geometrical figures -- Note: Including circles or ellipses containing bent or straight lines (except 26.1.10).Cercles ou ellipses contenant une ou plusieurs autres figures géométriques -- Note: Y compris les cercles ou ellipses contenant des lignes courbées ou droites (excepté 26.1.10).

Classification Information

Class [005]
Pharmaceuticals and herbicides

Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details

Serial Number

1551263

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 12 on 10^th Nov 2014	Extension of Time
Submitted for opposition 50 on 19^th Oct 2012	Allowed
Submitted for opposition 51 on 19^th Oct 2012	Allowance Notice Sent
Submitted for opposition 42 on 4^th Jul 2012	Advertised
Submitted for opposition 26 on 28^th Jun 2012	Approved
Submitted for opposition 22 on 8^th May 2012	Search Recorded
Submitted for opposition 27 on 8^th May 2012	Approval Notice Sent
Submitted for opposition 31 on 10^th Nov 2011	Formalized
Submitted for opposition 1 on 9^th Nov 2011	Created
Submitted for opposition 30 on 8^th Nov 2011	Filed